About
IGBRO-N
IGBRO-N Tablet is a prescription medication primarily used to manage respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, and cystic fibrosis. It is marketed by Innoglide pharmaceuticals Pvt.Ltd.
Each tablet contains:
Acebrophylline (100 mg): A bronchodilator and mucolytic agent that relaxes airway muscles and reduces inflammation.
N-Acetylcysteine (600 mg): A mucolytic agent that thins and loosens mucus in the airways, facilitating easier breathing.
Used to treat and prevent symptoms in:
- Asthma
- Chronic obstructive pulmonary disease (COPD)
- Acute or chronic bronchitis
- Cystic fibrosis complications
- Pneumonia-related respiratory issues
- Benefits include airway dilation and loosening of thick mucus, thereby easing breathing .
IGBRO-N is available by prescription only and should be used as directed by a healthcare professional.
Consult your healthcare provider for proper guidance on the use of IGBRO-N.